Harvest One Cannabis (TSXV: HVT) (OTCQX: HRVOF) has signed a distribution agreement with medicinal cannabis wholesale and distribution business Health House International Pty Ltd.
Under the terms of the agreement, Harvest One will supply Health House with Satipharm CBD 50mg Gelpell capsules.
The agreement was signed by Harvest One subsidiary Satipharm.
Health House will Distribute Satipharm across Australia
Health House is one of the major wholesalers to Australian pharmacies for medicinal cannabis. In May 2017, the company imported one of the first legal international medicinal cannabis shipments into Australia.
Under the agreement, Health House will distribute Satipharm’s medicinal cannabis products to their existing network of pharmacies.
The product will be available in Australia, while expanding distribution to New Zealand and Asia where and when legal.
“This agreement with Health House increases the availability of our Satipharm CBD 50mg Gelpell capsules across Australia, while expanding Satipharm’s medical cannabis distribution territories to New Zealand and Asia where and when legal” Grant Froese, the CEO of Harvest One, said in a statement.